Biotech News
Related news
XGNExagen2026-07-28 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conference
XGNExagen2026-08-04 12:00 EST
Exagen Inc. Reports Second Quarter 2026 Financial Results
LUCDLucid Diagnostics2026-08-04 12:30 EST
Lucid Diagnostics to Participate in Upcoming Investor Conferences
BDSXBiodesix2026-05-21 10:00 EST
Biodesix to Participate in Upcoming Investor Conferences
ATYRaTyr Pharma2026-05-13 20:01 EST
aTyr Pharma to Participate in Upcoming Investor Conferences
NRIXNurix Therapeutics2026-05-13 11:00 EST
Nurix Therapeutics to Participate in Upcoming Investor Conferences
APGEApogee Therapeutics2026-05-28 20:01 EST
Apogee Therapeutics to Participate in Upcoming June Conferences
ARGXArgenx2026-05-27 05:00 EST
argenx to Present at Upcoming Investor Conferences
GPCRStructure Therapeutics2026-05-26 20:05 EST
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
BDSXBiodesix2026-08-04 10:00 EST
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
Exagen
Autoimmune Diagnostics Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management. AVISE CTD AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines...
Recent company news
XGNExagen2026-08-04 12:00 EST
Exagen Inc. Reports Second Quarter 2026 Financial Results
XGNExagen2026-07-28 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conference
XGNExagen2026-07-21 13:00 EST
Exagen to Announce Second Quarter Financial Results on August 4, 2026
XGNExagen2026-06-01 13:00 EST
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
XGNExagen2026-05-11 12:00 EST
Exagen Inc. Reports First Quarter 2026 Results
Stock data
- Close
- 6.59 USD
- Market cap
- 116.45M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States